IGWM
AXSM icon

ICA Group Wealth Management’s Axsome Therapeutics AXSM Stock Holding History

ICA Group Wealth Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$798 – 822
2024
Q1 		$798 Buy
+10
New +$839 ﹤0.01% 1259

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICA Group Wealth Management's AXSM Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Axsome Therapeutics (AXSM) in Q2 2024, closing a stake of 10 shares — an estimated $798 sold.

ICA Group Wealth Management first reported a position in AXSM in Q1 2024 and held it in 1 quarter. The position peaked at $798 in Q1 2024. 257 funds tracked by Wall St. Rank hold AXSM as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Axsome Therapeutics position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 10 Axsome Therapeutics shares in Q2 2024, an estimated $798.
  • ICA Group Wealth Management first reported a position in Axsome Therapeutics in Q1 2024 and held it in 1 quarter.
  • ICA Group Wealth Management's Axsome Therapeutics position peaked at $798 in Q1 2024.
  • 257 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.